Opinion|Videos|January 31, 2025
Collaboration With Community Colleagues: Comanagement and Transitions of Care
Panelists discuss how effective co-management of chimeric antigen receptor (CAR) T patients requires clear communication protocols, standardized handoff procedures, and ongoing collaboration between academic centers and community practices to ensure safe transitions and optimal long-term monitoring.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Describe your institution’s approach to the comanagement and comonitoring of patients receiving CAR T therapy, particularly in the transition back to the community setting.
- Dr Usmani to ask Dr Tan: Can you share any specific strategies or tools your institution utilizes to facilitate seamless transitions of care between the academic center and community practices for CAR-T patients?
Advertisement
Related to this article
Hematologic specialists discussed where ciltacabtagene autoleucel fits in the treatment paradigm at first relapse and beyond in multiple myeloma.
Advertisement
Advertisement
Trending on CancerNetwork
1
Where Does Intensity-Modulated Proton Therapy Fit in Prostate Cancer?
2
Multimodal Biopsy Combo Shows Low Morbidity in Suspected Prostate Cancer
3
FDA Discussion Prompts Voluntary Withdrawal of BLA for I-DXd in ES-SCLC
4
SBRT Matches Disease Control of Prostatectomy in Localized Prostate Cancer
5